1
Home
Companies

Sino Biopharmaceutical

#1650

Rank

$11.06B

Marketcap

CN China

Country

Sino Biopharmaceutical
Leadership team

Ms. Y. Y. Tse (Exec. Chairwoman of the Board)

Mr. Eric S. Y. Tse (CEO & Exec. Director)

Mr. Ping Tse (Founder & Sr. Vice Chairman)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Hospital, Medical, Pharmaceutical
Number of Employees
20,000 - 50,000
Headquarters
Wan Chai, Hong Kong Island, Hong Kong
Established
1997
Net Income
500M - 1B
Revenue
Above - 1B
Traded as
1177.HK
Social Media
URL
https://www.sinobiopharm.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
History

Sino Biopharmaceutical was established in 1979 in Hong Kong and was one of the earlier pharmaceutical companies in the China region. In recent years, the company has grown rapidly, with an emphasis on innovation and the introduction of advanced technologies and world-class standards to develop and manufacture high-quality products and services.

Mission
Sino Biopharmaceutical’s mission is to enhance the health and wellbeing of people worldwide by providing innovative and high-quality products and services.
Vision
The vision of Sino Biopharmaceutical is to become the leading biopharmaceutical company in China and a global leader in providing innovative healthcare solutions.
Key Team

Ms. Cheung Ling Cheng (Exec. Vice Chairwoman of the Board)

Ms. Mingqin Li (VP & Exec. Director)

Mr. Zhoushan Tian (Exec. Director)

Mr. Hsin Tse (VP & Exec. Director)

Ms. Fai Chia (VP & Assistant to the Founding Chairman)

Dr. Wei Nong Ye (Assistant to Founding Chairman & GM of R&D Department)

Ms. Wun Tse (Assistant to the Founding Chairman)

Recognition and Awards
Sino Biopharmaceutical has won several industry awards, including the Hong Kong Business of the Year Award and the EuroAsia Business Council Award for Excellence in Innovation.
References

https://en.wikipedia.org/wiki/Sino_Biopharmaceutical_Limited

https://in.investing.com/equities/sino-biopharm

https://finance.yahoo.com/quote/1177.HK/profile?p=1177.HK

https://www.crunchbase.com/organization/sino-biopharmaceutical

https://companiesmarketcap.com/

https://www.sinobiopharm.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Sino Biopharmaceutical
Leadership team

Ms. Y. Y. Tse (Exec. Chairwoman of the Board)

Mr. Eric S. Y. Tse (CEO & Exec. Director)

Mr. Ping Tse (Founder & Sr. Vice Chairman)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Hospital, Medical, Pharmaceutical
Number of Employees
20,000 - 50,000
Headquarters
Wan Chai, Hong Kong Island, Hong Kong
Established
1997
Net Income
500M - 1B
Revenue
Above - 1B
Traded as
1177.HK
Social Media
URL
https://www.sinobiopharm.com